Literature DB >> 19694428

Amyloid-beta(1-42) fibrillar precursors are optimal for inducing tumor necrosis factor-alpha production in the THP-1 human monocytic cell line.

Deepa Ajit1, Maria L D Udan, Geeta Paranjape, Michael R Nichols.   

Abstract

Pathological studies have determined that fibrillar forms of amyloid-beta protein (Abeta) comprise the characteristic neuritic plaques in Alzheimer's disease (AD). These studies have also revealed significant inflammatory markers such as activated microglia and cytokines surrounding the plaques. Although the plaques are a hallmark of AD, they are only part of an array of Abeta aggregate morphologies observed in vivo. Interestingly, not all of these Abeta deposits provoke an inflammatory response. Since structural polymorphism is a prominent feature of Abeta aggregation both in vitro and in vivo, we sought to clarify which Abeta morphology or aggregation species induces the strongest proinflammatory response using human THP-1 monocytes as a model system. An aliquot of freshly reconstituted Abeta(1-42) in sterile water (100 microM, pH 3.6) did not effectively stimulate the cells at a final Abeta concentration of 15 microM. However, quiescent incubation of the peptide at 4 degrees C for 48-96 h greatly enhanced its ability to induce tumor necrosis factor-alpha (TNFalpha) production, the level of which surprisingly declined upon further aggregation. Imaging of the Abeta(1-42) aggregation solutions with atomic force microscopy indicated that the best cellular response coincided with the appearance of fibrillar structures, yet conditions that accelerated or increased the level of Abeta(1-42) fibril formation such as peptide concentration, temperature, or reconstitution in NaOH/PBS at pH 7.4 diminished its ability to stimulate the cells. Finally, depletion of the Abeta(1-42) solution with an antibody that recognizes fibrillar oligomers dramatically weakened the ability to induce TNFalpha production, and size-exclusion separation of the Abeta(1-42) solution provided further characterization of an aggregated species with proinflammatory activity. The findings suggested that an intermediate stage Abeta(1-42) fibrillar precursor is optimal for inducing a proinflammatory response in THP-1 monocytes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19694428      PMCID: PMC2749082          DOI: 10.1021/bi9003777

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  51 in total

1.  Amyloid beta-protein fibrillogenesis. Structure and biological activity of protofibrillar intermediates.

Authors:  D M Walsh; D M Hartley; Y Kusumoto; Y Fezoui; M M Condron; A Lomakin; G B Benedek; D J Selkoe; D B Teplow
Journal:  J Biol Chem       Date:  1999-09-03       Impact factor: 5.157

2.  Inflammation takes on Alzheimer disease.

Authors:  Todd E Golde
Journal:  Nat Med       Date:  2002-09       Impact factor: 53.440

3.  Insights into the amyloid folding problem from solid-state NMR.

Authors:  Robert Tycko
Journal:  Biochemistry       Date:  2003-03-25       Impact factor: 3.162

4.  Oligomeric amyloid beta associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques.

Authors:  Robert M Koffie; Melanie Meyer-Luehmann; Tadafumi Hashimoto; Kenneth W Adams; Matthew L Mielke; Monica Garcia-Alloza; Kristina D Micheva; Stephen J Smith; M Leo Kim; Virginia M Lee; Bradley T Hyman; Tara L Spires-Jones
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-19       Impact factor: 11.205

5.  Interaction of Alzheimer beta-amyloid peptide with the human monocytic cell line THP-1 results in a protein kinase C-dependent secretion of tumor necrosis factor-alpha.

Authors:  A Klegeris; D G Walker; P L McGeer
Journal:  Brain Res       Date:  1997-01-30       Impact factor: 3.252

6.  Amyloid fibril formation by A beta 16-22, a seven-residue fragment of the Alzheimer's beta-amyloid peptide, and structural characterization by solid state NMR.

Authors:  J J Balbach; Y Ishii; O N Antzutkin; R D Leapman; N W Rizzo; F Dyda; J Reed; R Tycko
Journal:  Biochemistry       Date:  2000-11-14       Impact factor: 3.162

7.  In vitro preparation of prefibrillar intermediates of amyloid-beta and alpha-synuclein.

Authors:  Hilal A Lashuel; Dolors Grillo-Bosch
Journal:  Methods Mol Biol       Date:  2005

8.  Amyloid beta-protein fibrillogenesis. Detection of a protofibrillar intermediate.

Authors:  D M Walsh; A Lomakin; G B Benedek; M M Condron; D B Teplow
Journal:  J Biol Chem       Date:  1997-08-29       Impact factor: 5.157

9.  Role of the toll-like receptor 4 in neuroinflammation in Alzheimer's disease.

Authors:  Silke Walter; Maryse Letiembre; Yang Liu; Holger Heine; Botond Penke; Wenlin Hao; Barbara Bode; Nicole Manietta; Jessica Walter; Walter Schulz-Schuffer; Klaus Fassbender
Journal:  Cell Physiol Biochem       Date:  2007

10.  Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

Authors:  A Lorenzo; B A Yankner
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

View more
  7 in total

Review 1.  The Aβ oligomer hypothesis for synapse failure and memory loss in Alzheimer's disease.

Authors:  Sergio T Ferreira; William L Klein
Journal:  Neurobiol Learn Mem       Date:  2011-09-06       Impact factor: 2.877

2.  Inflaming the diseased brain: a role for tainted melanins.

Authors:  T M Jeitner; M Kalogiannis; P A Patrick; I Gomolin; T Palaia; L Ragolia; D Brand; E J Delikatny
Journal:  Biochim Biophys Acta       Date:  2015-01-10

3.  Selective acetyl- and butyrylcholinesterase inhibitors reduce amyloid-β ex vivo activation of peripheral chemo-cytokines from Alzheimer's disease subjects: exploring the cholinergic anti-inflammatory pathway.

Authors:  Marcella Reale; Marta Di Nicola; Lucia Velluto; Chiara D'Angelo; Erica Costantini; Debomoy K Lahiri; Mohammad A Kamal; Qian-sheng Yu; Nigel H Greig
Journal:  Curr Alzheimer Res       Date:  2014       Impact factor: 3.498

4.  Nucleotides released from Aβ₁₋₄₂ -treated microglial cells increase cell migration and Aβ₁₋₄₂ uptake through P2Y₂ receptor activation.

Authors:  Hye Jung Kim; Deepa Ajit; Troy S Peterson; Yanfang Wang; Jean M Camden; W Gibson Wood; Grace Y Sun; Laurie Erb; Michael Petris; Gary A Weisman
Journal:  J Neurochem       Date:  2012-03-14       Impact factor: 5.372

5.  Isolated amyloid-β(1-42) protofibrils, but not isolated fibrils, are robust stimulators of microglia.

Authors:  Geeta S Paranjape; Lisa K Gouwens; David C Osborn; Michael R Nichols
Journal:  ACS Chem Neurosci       Date:  2012-01-09       Impact factor: 4.418

6.  Stability of early-stage amyloid-β(1-42) aggregation species.

Authors:  Kelley A Coalier; Geeta S Paranjape; Sanjib Karki; Michael R Nichols
Journal:  Biochim Biophys Acta       Date:  2012-08-25

7.  From the dual function lead AP2238 to AP2469, a multi-target-directed ligand for the treatment of Alzheimer's disease.

Authors:  Andrea Tarozzi; Manuela Bartolini; Lorna Piazzi; Luca Valgimigli; Riccardo Amorati; Cecilia Bolondi; Alice Djemil; Francesca Mancini; Vincenza Andrisano; Angela Rampa
Journal:  Pharmacol Res Perspect       Date:  2014-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.